icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
San Francisco
November 2018
Back grey_arrow_rt.gif
 
 
 
Short-Duration Sofosbuvir/Velpatasvir Safe and Effective in Treating HCV Infection Immediately After Liver Transplant
 
 
  Reported by Jules Levin
AASLD 2018 Nov 9-13 San Francisco
 
Edward J. Gane,1 Andrea Beckmann Fuentes,1 Robert H. Hyland,2 Sarah Arterburn,2 Evguenia Svarovskaia,2 Benedetta Massetto,2 Diana M. Brainard,2 Stephen Munn1 1New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand; 2Gilead Sciences, Inc., Foster City, CA

1113181

1113182

1113183

1113184

1113185